Glory Health Industry Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,036	2,705	2,506	3,905	9,898
Revenue Growth (YoY)	-61.72%	7.94%	-35.81%	-60.55%	71.58%
Cost of Revenue	1,344	2,150	2,557	3,791	8,651
Gross Profit	-308.09	555.56	-50.28	113.52	1,247
Selling, General & Admin	243.61	277.35	406.71	460.57	667.52
Operating Expenses	462.74	308.87	411.13	528.65	751.22
Operating Income	-770.83	246.7	-461.41	-415.14	496.02
Interest Expense	-783.78	-1,004	-502.67	-451.59	-744.91
Interest & Investment Income	0.24	65.58	73.56	74.26	83.94
Earnings From Equity Investments	-	-69.93	-72.56	42.03	166.39
Currency Exchange Gain (Loss)	61.88	-13.72	-18.76	-350.02	444.53
Other Non Operating Income (Expenses)	-101.4	-86.58	-24.29	-0.66	24.86
EBT Excluding Unusual Items	-1,594	-861.63	-1,006	-1,101	470.82
Gain (Loss) on Sale of Assets	-799.71	-17.72	146.12	2.45	332.01
Asset Writedown	47.88	-498.94	263.5	20.06	115.7
Other Unusual Items	444.08	-58.03	-58.95	-11.75	-41.66
Pretax Income	-1,902	-1,436	-655.46	-1,090	876.87
Income Tax Expense	-132.24	-20.81	-61.96	-95.05	532.35
Earnings From Continuing Operations	-1,769	-1,416	-593.5	-995.29	344.52
Minority Interest in Earnings	-53.09	175.07	29.53	82.51	-116.18
Net Income	-1,822	-1,240	-563.97	-912.78	228.33
Net Income to Common	-1,822	-1,240	-563.97	-912.78	228.33
Net Income Growth	-	-	-	-	131.25%
Shares Outstanding (Basic)	4,444	4,444	4,444	4,444	4,444
Shares Outstanding (Diluted)	4,444	4,444	4,444	4,444	4,444
EPS (Basic)	-0.41	-0.28	-0.13	-0.21	0.05
EPS (Diluted)	-0.41	-0.28	-0.13	-0.21	0.05
EPS Growth	-	-	-	-	131.42%
Free Cash Flow	-	678.26	452.11	413.47	4,066
Free Cash Flow Per Share	-	0.15	0.10	0.09	0.92
Gross Margin	-29.75%	20.54%	-2.01%	2.91%	12.60%
Operating Margin	-74.43%	9.12%	-18.41%	-10.63%	5.01%
Profit Margin	-175.98%	-45.85%	-22.50%	-23.38%	2.31%
Free Cash Flow Margin	-	25.07%	18.04%	10.59%	41.08%
EBITDA	-696.9	320.62	-384.83	-325.93	581.55
EBITDA Margin	-67.29%	11.85%	-15.35%	-8.35%	5.88%
D&A For EBITDA	73.93	73.93	76.58	89.2	85.53
EBIT	-770.83	246.7	-461.41	-415.14	496.02
EBIT Margin	-74.43%	9.12%	-18.41%	-10.63%	5.01%
Effective Tax Rate	-	-	-	-	60.71%
Revenue as Reported	1,036	2,705	2,506	3,905	9,898

Source: S&P Global Market Intelligence. Standard template. Financial Sources.